Better Health for All

Aeluma's core business involves photonic integrated circuits for data centers, telecommunications, LiDAR, and other sensing applications. While its technology has the potential for non-invasive blood glucose monitoring and skin-facing sensors for biological data,

there is no evidence that a significant portion of its current products or revenue is dedicated to health-related applications, leading to a neutral score for health impact. There is no evidence of revenue from products with negative health outcomes, nor any direct safety implications for users of its component products. The company's potential for more cost-effective and scalable health applications is noted, but there is no current evidence of specific pricing or accessibility programs for health products, or initiatives to reach vulnerable populations. While Aeluma is subject to general environmental and occupational safety laws, there is no specific information regarding the transparency of health risks or benefits of its products to users. The company's technology could address challenges in health-related applications, but no specific R&D budget allocation for health improvement is provided. There is no evidence of significant health externalities, health equity programs, healthcare workforce support, preventative health measures, healthcare data management, global health crisis response, or mental health initiatives. The company holds patents, but there is no information on its approach to patents in relation to global health needs. Aeluma does not produce food or nutritional products, does not engage in health education, its products do not have addiction potential, and it does not conduct clinical trials.

Fair Pay & Worker Respect

Aeluma, Inc. had 11 full-time and 2 part-time employees as of June 30, 2024.

None of the company's employees are represented by a labor union. The company has reported no material litigation, arbitration, governmental proceedings, or any other legal proceedings pending or known to be contemplated against it or its management team in their capacity as such, and they have not been subject to any such proceeding in the 10 years preceding the date of the report, indicating no significant labor-law or human-rights violations in the past two years.

Honest & Fair Business

Aeluma, Inc. has a Code of Business Conduct and Ethics that includes a whistle-blower policy, allowing employees to report suspected violations to their supervisor or CFO, with confidentiality protected where possible and retaliation prohibited.

However, there is no evidence of independent investigation processes for these reports. The company's Code also addresses FCPA compliance, prohibiting bribery, kickbacks, and other inducements to foreign officials, and requires CFO approval and reporting for facilitation payments. No information is provided regarding the frequency or effectiveness of training for this anti-corruption policy.

Kind to Animals

Aeluma, Inc. (ALMU.US) is a technology company focused on photonic integrated circuits and electronic components.

According to crueltyfreeinvesting.org in February 2026, the company has 'No Animal Exploitation'. Given its core business activities, Aeluma's operations do not involve animal testing, animal-derived ingredients, animal agriculture, or direct impact on wildlife habitats. Therefore, all animal welfare KPIs are assessed as not applicable to its business model.

No War, No Weapons

Aeluma, Inc. has secured contracts with the U.S. Navy for low-SWaP imaging sensors for submarines and high-speed photodetectors.

The company's technology is explicitly stated to be applicable to both defense/aerospace and commercial markets, including mobile and AI. One contract with the U.S. Navy is valued at up to $1.3 million. However, no information is provided regarding the percentage of company revenue derived from these defense contracts, the scope of R&D investment in dual-use technologies, or any ethical safeguards for potential military uses of AI systems. There is also no data on peacebuilding investments, conflict divestment policies, sales to embargoed regimes, or any other specific metrics required by the rubric.

Safe & Smart Tech

No specific, concrete evidence was found across the provided articles to assess Aeluma, Inc. against any of the 'Safe & Smart Tech' KPIs. All articles explicitly state 'no data provided' or 'no specific data' for metrics such as data breaches, AI ethics, cybersecurity investment, security training, encryption, AI audits, algorithmic transparency, unauthorized data use, user data control, authentication security, vulnerability management, bug bounty programs, privacy by design, security testing, data minimization, regulatory compliance, algorithmic harm remediation, and digital rights advocacy.

The ISO 9001:2015 certification mentioned is a quality management standard, not a privacy or security certification, and therefore does not provide relevant evidence for the 'privacy_certifications' or 'regulatory_compliance' KPIs.